Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

551 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Incidence of human cytomegalovirus infection in patients with refractory solid tumors receiving nonmyeloablative allogeneic stem cell transplants versus recipients of standard SCT for hematologic malignancies.
Zambelli A, Lilleri D, Pedrazzoli P, Peccatori J, Baldanti F, Fregoni V, Ciceri F, Caldera D, Renga M, Colombo AA, Alessandrino EP, Gerna G, Da Prada GA, Siena S, Bregni M. Zambelli A, et al. Among authors: baldanti f. Biol Blood Marrow Transplant. 2005 Jun;11(6):423-8. doi: 10.1016/j.bbmt.2005.02.005. Biol Blood Marrow Transplant. 2005. PMID: 15931630 Free article. Clinical Trial.
First case in Italy of acquired resistance to oseltamivir in an immunocompromised patient with influenza A/H1N1v infection.
Campanini G, Piralla A, Rovida F, Puzelli S, Facchini M, Locatelli F, Minoli L, Percivalle E, Donatelli I, Baldanti F; Surveillance Group for New Influenza A/H1N1v Investigation in Italy. Campanini G, et al. Among authors: baldanti f. J Clin Virol. 2010 Jul;48(3):220-2. doi: 10.1016/j.jcv.2010.03.027. Epub 2010 May 5. J Clin Virol. 2010. PMID: 20447860
T-cell therapy for EBV-associated nasopharyngeal carcinoma: preparative lymphodepleting chemotherapy does not improve clinical results.
Secondino S, Zecca M, Licitra L, Gurrado A, Schiavetto I, Bossi P, Locati L, Schiavo R, Basso S, Baldanti F, Maccario R, Locatelli F, Siena S, Pedrazzoli P, Comoli P. Secondino S, et al. Among authors: baldanti f. Ann Oncol. 2012 Feb;23(2):435-41. doi: 10.1093/annonc/mdr134. Epub 2011 May 17. Ann Oncol. 2012. PMID: 21586688 Free article.
Management of hepatitis C positive patients undergoing active treatment for malignancies: A position paper from the Associazione Italiana di Oncologia Medica (AIOM) and the Società Italiana di Malattie Infettive e Tropicali (SIMIT).
Bruno R, Zuccaro V, Pinto C, Puoti M, Gaeta GB, Pagani A, Taliani G, Baldanti F, Cinieri S, Pedrazzoli P. Bruno R, et al. Among authors: baldanti f. Semin Oncol. 2018 Oct;45(5-6):259-263. doi: 10.1053/j.seminoncol.2018.07.004. Epub 2018 Oct 25. Semin Oncol. 2018. PMID: 30482634 Review.
COVID-19 Vaccination in Fragile Patients: Current Evidence and an Harmonized Transdisease Trial.
Agrati C, Di Cosimo S, Fenoglio D, Apolone G, Ciceri F, Ciliberto G, Baldanti F, Costantini M, Giannarelli D, Ippolito G, Locatelli F, Mantovani A, Morrone A, Tagliavini F, Uccelli A, Zinzani PL, Silvestris N, Rescigno M. Agrati C, et al. Among authors: baldanti f. Front Immunol. 2021 Aug 10;12:704110. doi: 10.3389/fimmu.2021.704110. eCollection 2021. Front Immunol. 2021. PMID: 34447374 Free PMC article.
A snapshot of the immunogenicity, efficacy and safety of a full course of BNT162b2 anti-SARS-CoV-2 vaccine in cancer patients treated with PD-1/PD-L1 inhibitors: a longitudinal cohort study.
Lasagna A, Agustoni F, Percivalle E, Borgetto S, Paulet A, Comolli G, Sarasini A, Bergami F, Sammartino JC, Ferrari A, Zavaglio F, Arena F, Lilleri D, Secondino S, Falzoni M, Schiavo R, Klersy C, Lo Cascio G, Cavanna L, Baldanti F, Pedrazzoli P, Cassaniti I. Lasagna A, et al. Among authors: baldanti f. ESMO Open. 2021 Oct;6(5):100272. doi: 10.1016/j.esmoop.2021.100272. Epub 2021 Sep 1. ESMO Open. 2021. PMID: 34543863 Free PMC article.
551 results